Chemical industry – Page 71
-
Business
Europe approves stem cell therapy
Treatment for burn-damaged eyes uses patient’s own scaffold-grown cells
-
Business
Valeant to buy Salix for $14.5bn
Companies expect $500m in savings through ‘R&D rationalisation’
-
OpinionTantalising technology
Computer-assisted drug design always looks like it’s just about to work, says Derek Lowe, but the reality is complicated
-
BusinessHepatitis C drug patent challenged in Europe
Campaign group says Gilead’s expensive blockbuster sofosbuvir is not innovative enough to warrant a patent
-
Business
Teva wins generic esomeprazole race
US approval of heartburn drug after Ranbaxy version was withdrawn by regulators
-
Business
US approves internal tissue glue
Urethane-based TissuGlu aids healing after abdominal surgery
-
BusinessFertilising India's petrochemical industry
Rajesh Parishwad speaks to H N Ananth Kumar, India’s minister for chemicals and fertilisers
-
BusinessIndian chemical investment
By setting aside regions for joined-up investment plans, India hopes to become a significant player in the global petrochemical market. Rajesh Parishwad investigates
-
Business
Hospira buyout is a shot in the arm for Pfizer’s biosimilars
$17bn deal, intended to bolster sterile injectable and biologics capabilities, will be financed with existing cash and new debt
-
Business
WR Grace to split in half
Two daughter companies will focus on catalysts and speciality construction chemicals
-
Business
Tronox to buy FMC’s alkali chemicals
$1.6bn deal helps Tronox strengthen its inorganics portfolio as FMC shifts towards agrochemicals
-
Business
Fatal blast at Indian chemical plant
One worker killed and four injured at Survival Technologies plant in Ankleshwar
-
Business
EU regulator calls for generic drug suspensions
The EMA wants hundreds of formulations off the market after identifying systematic fraud in a major Indian contract clinical research organisation
-
BusinessRoche chases bolt-on acquisitions as it pushes into genomics
Company’s recent shopping spree aims to harness genome sequencing to advance personalised treatments
-
Business
UK calls for fracking restrictions
Environment committee wants to protect national parks and tighten regulation
-
Business
Shire deepens rare disease focus with NPS buyout
Approval of parathyroid hormone drug further validates acquisition decision
-
Business
US methane emissions reduction effort generates sparks
White House targets oil and gas sector but gets a chilly reception from Republican lawmakers and industry
-
Business
MFG Chemical fined after worker dies
Company cited for multiple safety failings before the fatal incident
-
Business
Ansun settles fraud case for $2m
Executives fiddled timesheets to overcharge US funding agency on grants and research contracts
-
Business
Biogen Idec to buy Convergence for pain pipeline
UK firm will remain intact as a ‘centre of excellence’ in pain R&D for Biogen